BIOCRYST PHARMACEUTICALS, INC.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2018 | — | -456.2% | -490.3% |
| FY2019 | 92.4% | -203.7% | -223.0% |
| FY2020 | 91.3% | -981.1% | -1,026.4% |
| FY2021 | 95.4% | -113.1% | -117.1% |
| FY2022 | 97.6% | -54.8% | -91.2% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2018 | — | -456.2% | -490.3% |
| FY2019 | 92.4% | -203.7% | -223.0% |
| FY2020 | 91.3% | -981.1% | -1,026.4% |
| FY2021 | 95.4% | -113.1% | -117.1% |
| FY2022 | 97.6% | -54.8% | -91.2% |